Copyright
©The Author(s) 2020.
World J Stem Cells. Sep 26, 2020; 12(9): 966-985
Published online Sep 26, 2020. doi: 10.4252/wjsc.v12.i9.966
Published online Sep 26, 2020. doi: 10.4252/wjsc.v12.i9.966
Ref. | Species | Tissue sources | Classification | Cells | Groups | Database | Differentially expressed genes (DEGs) | Identification of targets |
Benisch et al[48], 2012 | Human | Bone marrow of femoral heads | Affymetrix Gene Chip | Cultured in DMEM/Ham’s F-12 (1:1) medium supplemented with 10% fetal calf serum (FCS), 1 U/mL penicillin, 100 μg/mL streptomycin, and 50 μg/mL L-ascorbic acid 2-phosphate. Used after 1 to 2 passages | hMSC-C: Middle-aged donors (42-67 yr old); hMSC-old: The age-matched control group (79-89 yr old); hMSC-OP: Patients (79-94 yr old) who had primary osteoporosis; hMSC-senescent: Healthy donors of middle-age (42-64 yr old) until they entered senescence | GEO accession numbers: GSE35955; GSE35956; GSE35957; GSE35958; GSE35959 | One gene was upregulated and seven downregulated in all three groups, compared with the hMSC-C group; 38 genes with enhanced and 36 genes with reduced expression in hMSC-OP and hMSC-old groups, compared with hMSC-C; 2477 genes with higher and 1222 genes with lower expression in hMSC-OP, in comparison with hMSC-old | The reliable or promising candidates for osteoporosis, including susceptibility genes: Lrp5, Spp1 (Osteopontin), Col1a1, Sost, and Mab21l1 |
Yoo et al[50], 2013 | Human | Bone marrow-derived MSCs | SSH analysis | Purchased from Cambrex Bio Science | Young human MSCs (Y-hMSCs): Approximately 10 population doubling levels (PDL); senescent MSCs (S-hMSCs): Until approximately 30 PDL, at least 80% of the cells were positive for SA-β-Gal staining | NA | Nineteen genes were down-regulated and 43 upregulated in S-hMSCs | Gradually downregulated mRNA in S-hMSCs: Pdia3, Wdr1, Fstl1, Copg1, Lman1, and Pdia6; significantly upregulated genes: Hsp90b1, Eid1, Atp2b4, Ddah1, Prnp, Rab1a, Psg5, Tm4sf1, and Ssr3 |
Bustos et al[52], 2014 | Mouse | Bone marrow | Affymetrix Gene Chip | Sorted by fluorescence-activated cell sorting (FACS) | BM-MSCs from young (3-mo-old) and aged (24-mo-old) mice; young donor BM-MSCs vs aged ones | GEO accession number: GSE44403 | 927 genes were differentially expressed | Confirmed by qPCR: Cytokine receptors (15 genes), chemokines (Ccr7, Cxc3cr1, Cxcr5), markers of cell senescence (CDK, p21, p27, and p53), Marcks, Mmp9, and Timp2 |
Duscher et al [54], 2014 | Mouse | Inguinal fat pads | Microfluidic-based single-cell gene expression platform | CD45-/CD31-/CD34+ cells were sorted | Adipose-derived mesenchymal stem cells (ADSCs) from young (3 mo) and aged (21 mo) mice | NA | Differences in transcriptional profiles of genes related to cell stemness, remodeling, and vasculogenesis: Adam10, Angpt1, Angpt2, Hif1a, Mef2c, and Sod2 | Age-related depletion of a subpopulation of MSCs characterized by a pro-vascular transcriptional profile, such as Angpt1, Vegfa, and Sod3 |
Medeiros et al[19], 2017 | Human | Umbilical cord veins | The GeneChip Human Genome U133 Plus 2.0 array | The surface markers including CD105, CD73, CD90, CD14, CD34, and CD45 were analyzed by flow cytometry; differentiation capacity toward three lineages was assessed | hMSCs in the 9th (Y-hMSCs) and 18th passages (S-hMSCs) were used for assays, hMSCs/n from the donor with normal karyotype, and hMSCs/inv from the donor with a constitutional inversion of chromosome 3; the comparisons were as follows: (1) Y-hMSCs/n & S-hMSC/n; (2) Y-hMSCs/inv & S-hMSCs/inv; (3) Y-hMSCs/n & Y-hMSCs/inv; and (4) S-hMSCs/n & S-hMSCs/inv | GEO accession number: GSE56530 | 73 DEGs in S-hMSCs/n compared with Y-hMSCs/n and 279 DEGs in S-hMSCs/inv compared with Y-hMSCs/inv; 93 DEGs in Y-hMSCs/inv compared with Y-hMSCs/n; 425 DEGs in S-hMSCs/inv compared with S-hMSCs/n. The candidates for senescent markers: Dio2, Foxe1, Galnt5, Has3, Krt19, Krt34, Krtap1-55, Oc730755, Mrvi1, Plcb4, and Scube3 | Confirmed by qPCR: Ankrd1 and Mmp1 in S-hMSC/n vs Y-hMSC/n; Sfrp1, Ankrd1, G0s2, and Ndn in S-hMSC/inv vs Y-hMSC/inv; Adora2b, Sfrp1, Kynu, G0s2, Aldh1a1, and Mab21l1 in Y-hMSC/inv vs Y-hMSC/inv; and Adora2b, Ccl7, Sfrp1, Kynu, Ankrd1, Mmp1, Lamc2, G0s2, M ab21l1, and Ndn in S-hMSC/inv vs S-hMSC/n |
Wu et al[49], 2019 | Human | Bone marrow of femoral heads | Affymetrix Gene Chip | Cultured in DMEM/Ham’s F-12 (1:1) medium supplemented with 10% FCS, 1 U/mL penicillin, 100 μg/mL streptomycin, and 50 μg/mL L-ascorbic acid 2-phosphate. used after 1 to 2 passages | Middle-aged group vs elderly group | GEO accession number: GSE35955 | 156 up-regulated and 343 down-regulated differentially expressed genes (DEGs) | Six hub genes identified by PPI network analysis: Ctnnb1, Ppp2r1a, Fyn, Mapk1, Pik3c2a and Ep300. 11 TFs identified by TFs screening: Creb1, Cux1, Egr1, Ep300, Foxc1, Hsf2, Mef2a, Plau, Sp1, Stat1 and Usf1 |
Wiese et al[47], 2019 | Human | The perivascular region of Wharton’s jelly from umbilical cords | Affymetrix GeneChip U133A 2.0 arrays | Provided by Tissue Regeneration Therapeutics, Inc. Positive for the cell surface markers CD73, CD90, CD105, CD10, CD140b, CD146 (40%-60%), CD166, and MHC-I; negative for the cell surface markers CD45, CD31, CD34, and HLA-DR. Exhibit trilineage potential in directed differentiation assays | Human umbilical cord perivascular cells (HUCPVCs) from early passages (P2–P5), mid-passages (P6–P9), and pre-senescent passages (P10–P12) | GEO accession number: GSE119987 | The transcriptome of HUCPVCs was stable through P5. A single significantly DE gene was identified at P6 and P7 compared with P2, whereas 5 DE genes were detected at P8 and 27 at P9. The number of significantly DE probe sets increased from 27 (P9) to 301 (P10), then to 1094 (P12) | Significant transcriptome drift occurred only after P5 |
Leveque et al[51], 2019 | Human | Bone marrow aspirates from the iliac crest of healthy donors (21 to 26 years old) | RNAseq Analysis | The surface markers including CD34, CD45, CD73, CD90, and CD105 were analyzed by flow cytometry; differentiation capacity toward three lineages was assessed | Four groups: Control MSCs (P3); 21 d pesticide mixture exposed MSCs (P4); long-term cultivated MSCs (P14); and MSCs from aging donor (72 yr old) | The SRA database under accession number PRJNA510912 | 394, 1073, and 2077 EST were significantly increased from pesticide exposed, P14 MSCs, and MSC from aged donor; 218, 1077, and1571 ESTs were down-regulated | Confirmed by QPCR: Igf-1, Prolactin, Leptin, and Cox-2 |
- Citation: Meng QS, Liu J, Wei L, Fan HM, Zhou XH, Liang XT. Senescent mesenchymal stem/stromal cells and restoring their cellular functions. World J Stem Cells 2020; 12(9): 966-985
- URL: https://www.wjgnet.com/1948-0210/full/v12/i9/966.htm
- DOI: https://dx.doi.org/10.4252/wjsc.v12.i9.966